Unlock instant, AI-driven research and patent intelligence for your innovation.

Medicinal composition for treating alzheimer disease and application thereof

A technology for Alzheimer's disease and a composition, which is applied in the field of medicine, can solve the problems such as the combination of galantamine and nimodipine that has not yet been seen, and achieves good clinical drug development prospects, good synergy, and good biological effects. Effect

Inactive Publication Date: 2014-12-10
朱忠良
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] At present, there is no report on the combination of galantamine and nimodipine

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] Embodiment 1: Modified Ellman method evaluates the activity of galantamine and nimodipine to inhibit acetylcholinesterase

[0024] 1. Instruments and materials

[0025] Instruments: BioTek Synergy2 multifunctional microplate reader (BioTek, USA), high-speed cryogenic centrifuge (Sovall Evolution RC, Kendro Corporation), vortex shaker (Vortex-Genie2, Scientific Industries, USA).

[0026] Reagents: acetylcholinesterase (AchE, from electric eel, enzyme activity: 687U / mg protein, Mr280kDa), acetylthiocholine iodide (AchE, AchE substrate, Mr289.2); 5,5'- Dithio-linked (2-nitrobenzoic acid) (5,5-dithiobis (2-nitro) benzoic acid, DTNB) were purchased from Sigma–Aldrich (St.Louis, MO, USA); ultrapure water (Millipore, The United States), Tris-hydroxymethylaminomethane Tris-base (Biosharp, South Korea), and other reagents are of analytical grade.

[0027] 2. Solution preparation

[0028] Tris / HCl buffer: 20mM Tris buffer, containing 100mM NaCl, pH 7.5; AChE solution: take ACh...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medicinal composition for treating an alzheimer disease and an application thereof. The medicinal composition comprises galanthamine and nimodipine which serve as active ingredients, wherein the weight ratio of the galanthamine to the nimodipine is 1:3 to 3:1; the medicinal composition has a good synergistic effect when being used for treating the alzheimer disease, and the effect of treating the alzheimer disease when the galanthamine and the nimodipine are jointly used is obviously superior to that when one of the galanthamine and the nimodipine is used. The medicinal composition and the application thereof have the benefits that the biological effect generated by the medicinal composition can be better than that generated by a monomer during the low dose compatibility, the generation of toxic or side effectss of the medicinal composition can be greatly reduced, and the clinical medicine development prospect is good.

Description

technical field [0001] The present invention relates to the technical field of medicine, in particular to a pharmaceutical composition for treating Alzheimer's disease and its application. The pharmaceutical composition contains galantamine and nimodipine as active ingredients. Background technique [0002] Alzheimer's disease (AD) is a degenerative disease of the central nervous system, clinically manifested as severe cognitive and memory dysfunction and decreased social adaptability. Its pathogenesis is complex and its etiology has not been fully elucidated. Among them, acetylcholinesterase inhibitor (AChEI) is the most mature and successful method for the treatment of AD. It is a first-class drug and is regarded as the standard treatment for mild to moderate AD patients. AChEIs mainly include donepezil, rivastigmine, tacrine and the alkaloids galanthamine and huperzine A extracted from plants. [0003] Among them, galantamine is one of the drugs of first choice for the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/55A61P25/28A61K31/4422
Inventor 朱忠良
Owner 朱忠良
PatSnap Eureka logo

PatSnap Eureka turns technology decisions into work you can execute. Powered by our Innovation Knowledge Graph, it runs expert workflows across engineering, life sciences, materials and intellectual property. Get your review-ready output in minutes.

X (Twitter)LinkedInYouTubeSubstack

© 2026 PatSnap. All rights reserved. 

Terms of Service

 | 

Privacy policy

 | 

Modern Slavery Act Transparency Statement